Eman El‐Ahwany

1.8k total citations
57 papers, 1.3k citations indexed

About

Eman El‐Ahwany is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Eman El‐Ahwany has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 23 papers in Cancer Research and 15 papers in Hepatology. Recurrent topics in Eman El‐Ahwany's work include MicroRNA in disease regulation (15 papers), Liver Disease Diagnosis and Treatment (10 papers) and Parasites and Host Interactions (8 papers). Eman El‐Ahwany is often cited by papers focused on MicroRNA in disease regulation (15 papers), Liver Disease Diagnosis and Treatment (10 papers) and Parasites and Host Interactions (8 papers). Eman El‐Ahwany collaborates with scholars based in Egypt, Saudi Arabia and Romania. Eman El‐Ahwany's co-authors include Sameh Saber, Mona Zoheiry, Suher Zada, Marwa Hassan, Walied Abdo, Noha A. Amin, Amr A. A. Mahmoud, Eslam E. Abd El-Fattah, Amal M. H. Ghanim and Ahmed Shata and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Eman El‐Ahwany

54 papers receiving 1.2k citations

Peers

Eman El‐Ahwany
Qunyan Yao China
Jin‐Yong Zhou China
Xiaoqun Duan China
Miao Shen China
Jiaxin Zhang China
Angeliki Xagorari Greece
Shuncai Zhang China
Jeng‐Jer Shieh Taiwan
Chunli Wu China
Xuelian Zhao China
Qunyan Yao China
Eman El‐Ahwany
Citations per year, relative to Eman El‐Ahwany Eman El‐Ahwany (= 1×) peers Qunyan Yao

Countries citing papers authored by Eman El‐Ahwany

Since Specialization
Citations

This map shows the geographic impact of Eman El‐Ahwany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman El‐Ahwany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman El‐Ahwany more than expected).

Fields of papers citing papers by Eman El‐Ahwany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman El‐Ahwany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman El‐Ahwany. The network helps show where Eman El‐Ahwany may publish in the future.

Co-authorship network of co-authors of Eman El‐Ahwany

This figure shows the co-authorship network connecting the top 25 collaborators of Eman El‐Ahwany. A scholar is included among the top collaborators of Eman El‐Ahwany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman El‐Ahwany. Eman El‐Ahwany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El-Maadawy, Walaa H., et al.. (2025). Forskolin alleviates cholestatic liver disease by inhibiting the Hippo/YAP-mediated ductular reaction and fibrosis progression. European Journal of Pharmacology. 1006. 178182–178182.
2.
Hassan, Marwa, Iker Badiola, Alejandro Sánchez, et al.. (2025). Therapeutic potential of miRNA-26a-encapsulated nanoparticles against hepatocellular carcinoma in a murine model. Liver Research. 9(4). 338–350.
3.
Hassan, Marwa, et al.. (2023). Innovative model of surface-enhanced Raman spectroscopy for exosomes identification: An approach for the diagnosis of hepatocellular carcinoma. Clinica Chimica Acta. 540. 117228–117228. 14 indexed citations
4.
El‐Ahwany, Eman, et al.. (2022). Association of Sat-a and Alu methylation status with HCV-induced chronic liver disease and hepatocellular carcinoma. Virus Research. 321. 198928–198928. 2 indexed citations
5.
El-Fattah, Eslam E. Abd, Sameh Saber, Ahmed A.E. Mourad, et al.. (2022). The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury. Biomedicine & Pharmacotherapy. 147. 112628–112628. 60 indexed citations
6.
Shaaban, Ahmed A., A. M. Abdelhamid, Simona Cavalu, et al.. (2022). Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis. Biomedicine & Pharmacotherapy. 153. 113247–113247. 19 indexed citations
7.
El-Fattah, Eslam E. Abd, Sameh Saber, Mahmoud E. Youssef, et al.. (2022). AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma. Frontiers in Pharmacology. 12. 720173–720173. 19 indexed citations
8.
9.
10.
El‐Ahwany, Eman, et al.. (2021). Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma. Molecular Biology Reports. 48(7). 5549–5559. 14 indexed citations
11.
Saber, Sameh, et al.. (2018). Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk. Toxicology and Applied Pharmacology. 364. 120–132. 142 indexed citations
12.
El‐Ahwany, Eman, et al.. (2018). miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Virus Research. 253. 135–139. 35 indexed citations
13.
El‐Ahwany, Eman, et al.. (2016). Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis. SHILAP Revista de lepidopterología. 8(1). 1804–1810. 22 indexed citations
14.
El‐Ahwany, Eman, et al.. (2016). The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patient. SHILAP Revista de lepidopterología. 8(2). 1994–2000. 1 indexed citations
15.
Amer, Marwa, et al.. (2013). 283 PREDICTION OF miRNA TARGET GENES INVOLVED IN LIVER CANCER PATHWAYS AND ITS VALIDATION. Journal of Hepatology. 58. S120–S120. 1 indexed citations
16.
El‐Ahwany, Eman, et al.. (2012). Protective Role of Purified Cysteine Proteinases against Fasciola gigantica Infection in Experimental Animals. Korean Journal of Parasitology. 50(1). 45–51. 9 indexed citations
17.
18.
Aboushousha, Tarek, et al.. (2009). Hepatic mRNA expression of histone (H3): an early predictor of tumorgenic changes in chronic hepatitis C. Archives of Medical Science. 5(4). 506–512. 2 indexed citations
19.
El‐Ahwany, Eman, et al.. (2009). Down-regulation of intrahepatic CD16 + and CD56 + immune cells in chronic Hepatitis C virus infection and HCV-related hepatocellular carcinoma. Archives of Medical Science. 5(3). 321–328. 2 indexed citations
20.
El‐Ahwany, Eman, et al.. (2000). Immunolocalization of macrophage adhesion molecule-1 and macrophage inflammatory protein-1 in schistosomal soluble egg antigen-induced granulomatous hyporesponsiveness. International Journal for Parasitology. 30(7). 837–842. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qunyan Yao Breakdown of academic impact, for papers by Jin‐Yong Zhou Breakdown of academic impact, for papers by Xiaoqun Duan Breakdown of academic impact, for papers by Miao Shen Breakdown of academic impact, for papers by Jiaxin Zhang Breakdown of academic impact, for papers by Angeliki Xagorari Breakdown of academic impact, for papers by Shuncai Zhang Breakdown of academic impact, for papers by Jeng‐Jer Shieh Breakdown of academic impact, for papers by Chunli Wu Breakdown of academic impact, for papers by Xuelian Zhao
Rankless by CCL
2026